Press release
Necrotizing Enterocolitis Pipeline Analysis, 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies by DelveInsight | Abbott, Astellas Pharma, Bayer, Becton, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly
Necrotizing Enterocolitis Pipeline
"Necrotizing Enterocolitis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Necrotizing Enterocolitis Market.
The Necrotizing Enterocolitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Necrotizing Enterocolitis Pipeline Report: https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
• Necrotizing Enterocolitis Companies across the globe are diligently working toward developing novel Necrotizing Enterocolitis treatment therapies with a considerable amount of success over the years.
• Necrotizing Enterocolitis companies working in the treatment market are NEC Evolve Biosystems, Siolta Therapeutics, Noveome Biotherapeutics, Micregen Ltd, Infant Bacterial Therapeutics, The Emmes Company, LLC, and others, are developing therapies for the Necrotizing Enterocolitis treatment
• Emerging Necrotizing Enterocolitis therapies in the different phases of clinical trials are- Research Programme, STMC-106, ST266, MRG1061, IBP-9414, meropenem, and others are expected to have a significant impact on the Necrotizing Enterocolitis market in the coming years.
• In January 2023, The British Journal of Gastroenterology provides clinical findings from Infant Bacterial Therapeutics (IBT) regarding the compelling correlation between clinical events and the feeding primary goal of the "ConnectionStudy." Two separate primary objectives are being tracked in the "Connection Study" about the pharmaceutical grade probiotic IBP-9414: the incidence of necrotizing enterocolitis (NEC) and the time to a rigorous definition of sustained feeding tolerance (SFT).
• In January 2022, The Australian Patent Office has issued a patent entitled "A method of activating lactic acid bacteria," which protects the formulation of Lactobacillus reuteri, including IBP-9414, according to a statement released by Infant Bacterial Therapeutics AB. Phase III research on IBP9414 is aimed at preventing necrotizing enterocolitis (NEC) and enhancing feeding tolerance in premature newborns.
Necrotizing Enterocolitis Overview
The debilitating condition known as necrotizing enterocolitis (NEC) primarily attacks the intestines of premature newborns. Bacteria infiltrate the intestinal wall, resulting in localized infection and inflammation that may eventually lead to the wall's destruction (intestine). Such damage to the bowel wall may result in intestinal perforation and the leakage of stool into the baby's abdomen, potentially leading to a fatal infection.
Get a Free Sample PDF Report to know more about Necrotizing Enterocolitis Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/necrotizing-enterocolitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Emerging Necrotizing Enterocolitis Drugs Under Different Phases of Clinical Development Include:
• Research Programme: NEC Evolve Biosystems
• STMC-106: Siolta Therapeutics
• ST266: Noveome Biotherapeutics
• MRG1061: Micregen Ltd
• IBP-9414: Infant Bacterial Therapeutics
• meropenem: The Emmes Company, LLC
Necrotizing Enterocolitis Route of Administration
Necrotizing Enterocolitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical.
• Molecule Type
Necrotizing Enterocolitis Molecule Type
Necrotizing Enterocolitis Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type
Necrotizing Enterocolitis Pipeline Therapeutics Assessment
• Necrotizing Enterocolitis Assessment by Product Type
• Necrotizing Enterocolitis By Stage and Product Type
• Necrotizing Enterocolitis Assessment by Route of Administration
• Necrotizing Enterocolitis By Stage and Route of Administration
• Necrotizing Enterocolitis Assessment by Molecule Type
• Necrotizing Enterocolitis by Stage and Molecule Type
DelveInsight's Necrotizing Enterocolitis Report covers around 4+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Necrotizing Enterocolitis product details are provided in the report. Download the Necrotizing Enterocolitis pipeline report to learn more about the emerging Necrotizing Enterocolitis therapies
https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Necrotizing Enterocolitis Therapeutics Market include:
Key companies developing therapies for Necrotizing Enterocolitis are - Abbott, Astellas Pharma Inc., Bayer HealthCare AG, Becton, Dickinson, and Company (BD), Bristol-Myers Squibb Company, Daiichi Sankyo Company, Ltd., Eli Lilly and Co., Enzon Pharmaceuticals, Inc., Hoffmann-La Roche Ltd, GI Supply, GlaxoSmithKline Plc, and others.
Necrotizing Enterocolitis Pipeline Analysis:
The Necrotizing Enterocolitis pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Necrotizing Enterocolitis with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Necrotizing Enterocolitis Treatment.
• Necrotizing Enterocolitis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Necrotizing Enterocolitis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Necrotizing Enterocolitis market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Necrotizing Enterocolitis drugs and therapies
https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Necrotizing Enterocolitis Pipeline Market Drivers
• Increasing contribution towards the research and development activities, improved regulatory framework by the Government towards the development of new antibiotics and therapies are some of the important factors that are fueling the Necrotizing Enterocolitis Market.
Necrotizing Enterocolitis Pipeline Market Barriers
• However, high cost associated with the treatment, lack of skilled healthcare professionals to carry out the diagnosis and other factors are creating obstacles in the Necrotizing Enterocolitis Market growth.
Scope of Necrotizing Enterocolitis Pipeline Drug Insight
• Coverage: Global
• Key Necrotizing Enterocolitis Companies: NEC Evolve Biosystems, Siolta Therapeutics, Noveome Biotherapeutics, Micregen Ltd, Infant Bacterial Therapeutics, The Emmes Company, LLC, and others
• Key Necrotizing Enterocolitis Therapies: Research Programme, STMC-106, ST266, MRG1061, IBP-9414, meropenem, and others
• Necrotizing Enterocolitis Therapeutic Assessment: Necrotizing Enterocolitis current marketed and Necrotizing Enterocolitis emerging therapies
• Necrotizing Enterocolitis Market Dynamics: Necrotizing Enterocolitis market drivers and Necrotizing Enterocolitis market barriers
Request for Sample PDF Report for Necrotizing Enterocolitis Pipeline Assessment and clinical trials
https://www.delveinsight.com/sample-request/necrotizing-enterocolitis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Necrotizing Enterocolitis Report Introduction
2. Necrotizing Enterocolitis Executive Summary
3. Necrotizing Enterocolitis Overview
4. Necrotizing Enterocolitis- Analytical Perspective In-depth Commercial Assessment
5. Necrotizing Enterocolitis Pipeline Therapeutics
6. Necrotizing Enterocolitis Late Stage Products (Phase II/III)
7. Necrotizing Enterocolitis Mid Stage Products (Phase II)
8. Necrotizing Enterocolitis Early Stage Products (Phase I)
9. Necrotizing Enterocolitis Preclinical Stage Products
10. Necrotizing Enterocolitis Therapeutics Assessment
11. Necrotizing Enterocolitis Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Necrotizing Enterocolitis Key Companies
14. Necrotizing Enterocolitis Key Products
15. Necrotizing Enterocolitis Unmet Needs
16 . Necrotizing Enterocolitis Market Drivers and Barriers
17. Necrotizing Enterocolitis Future Perspectives and Conclusion
18. Necrotizing Enterocolitis Analyst Views
19. Appendix
20. About DelveInsight
Trending Reports:
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Polycythemia Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Ambulatory Arrhythmia Monitoring Devices Market: https://www.delveinsight.com/report-store/ambulatory-arrhythmia-monitoring-devices-market
• Choroidal Neovascularization Market: https://www.delveinsight.com/report-store/choroidal-neovascularization-market
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Cardiopulmonary Bypass Equipment Market: https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market
• Chemotherapy Induced Anemia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-anemia-market
• Chronic Bronchitis Market: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market
• Clbp Market: https://www.delveinsight.com/report-store/chronic-lower-back-pain-clbp-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Pemphigus Vulgaris Market: https://www.delveinsight.com/infographics/pemphigus-vulgaris-market
• Polycythemia Vera Market: https://www.delveinsight.com/report-store/polycythemia-vera-market
• Advanced Renal Cell Carcinoma Market: https://www.delveinsight.com/report-store/advanced-renal-cell-carcinoma-rcc-market
• Airway Stent Market Market: https://www.delveinsight.com/report-store/airway-stent-market
• Allergic Conjunctivitis Market: https://www.delveinsight.com/report-store/allergic-conjunctivitis-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alport Syndrome Market: https://www.delveinsight.com/report-store/alport-syndrome-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Bladder Pain Syndrome Market: https://www.delveinsight.com/report-store/interstitial-cystitis-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Brain Aneurysm Stents Market: https://www.delveinsight.com/report-store/brain-aneurysm-stents-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-market
• Chronic Inflammatory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Inflammtory Demyelinating Polyneuropathy Market: https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myeloid-leukemia-market
• Cutaneous T-cell Lymphoma Market: https://www.delveinsight.com/report-store/cutaneous-t-cell-lymphoma-ctcl-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Eczema Market: https://www.delveinsight.com/report-store/atopic-dermatitis-market
Contact Info:
Ankit Nigam
Assistant Manager (Marketing & Branding)
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Necrotizing Enterocolitis Pipeline Analysis, 2024: Clinical Trials, FDA Approvals, Therapies, ROA, MOA and Key Companies by DelveInsight | Abbott, Astellas Pharma, Bayer, Becton, Bristol-Myers Squibb, Daiichi Sankyo, Eli Lilly here
News-ID: 3466455 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Necrotizing
Necrotizing Enterocolitis (NEC) Market to Reach USD 1.4 Billion by 2034
Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease that primarily affects premature and low-birth-weight infants. It is characterized by intestinal inflammation, necrosis, and in some cases, perforation, leading to life-threatening complications. NEC remains one of the most serious conditions in neonatal intensive care units (NICUs), associated with high morbidity, mortality, and long-term health consequences such as short bowel syndrome and neurodevelopmental impairment.
Although the exact cause of NEC remains unclear, risk…
Necrotizing Enterocolitis Pipeline: Breakthrough Therapeutics Advancing in Neona …
Necrotizing Enterocolitis (NEC), a devastating gastrointestinal disease affecting neonates, especially preterm infants, has long lacked effective treatment beyond supportive care. However, innovative biotech companies such as Infant Bacterial Therapeutics and Noveome Biotherapeutics are advancing novel therapies, including live biotherapeutics, probiotics, and anti-inflammatory agents to combat NEC at its roots.
DelveInsight's "Necrotizing Enterocolitis - Pipeline Insight, 2025" tracks the progress of these emerging therapies, offering a granular view of the clinical pipeline,…
Necrotizing Enterocolitis Drugs Market Forecast 2023-2030
Advancements in Necrotizing Enterocolitis Market Attract Significant Research and Investment:
The necrotizing enterocolitis (NEC) market is experiencing a surge in research activities and technological advancements, driven by the launch of new antibiotics and antifungals for NEC treatment. Noteworthy players like Noveome Biotherapeutics, Inc., Pfizer Inc., Endo Pharmaceuticals Inc., and Sanofi are actively contributing to the market's growth.
The rising availability of approved antibiotics, increased cases of NEC, and intensified research and development…
Global Necrotizing Autoimmune Myositis Market - Opportunities & Forecasts, 2020- …
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global necrotizing autoimmune myositis market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future.
Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able…
Necrotizing Fasciitis Treatment
Necrotizing Fasciitis Treatment Market describes its growth, size, share, Forecast and trends to 2025
Necrotizing Fasciitis Treatment Market Production and Demand Analysis 2019 to 2025
Necrotizing Fasciitis Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025
Necrotizing Fasciitis Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Necrotizing Fasciitis Treatment Market to Insight By 2025: Top Key Vendors
Necrotizing fasciitis NF, commonly known as flesh-eating disease, is an infection that results in…
Global Necrotizing Skin infections Treatment Market Size, Status and Forecast 20 …
Market Research Report Store offers a latest published report on Necrotizing Skin infections Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Necrotizing Skin infections Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Necrotizing Skin…
